<s id="fzjui"><acronym id="fzjui"><u id="fzjui"></u></acronym></s>

  1. <dd id="fzjui"><center id="fzjui"></center></dd>

    <nav id="fzjui"></nav>



    當前位置:首頁 >產品中心>細胞庫>人正常細胞>CRL-11610RWPE-2 人前列腺正常細胞

    RWPE-2 人前列腺正常細胞

    簡要描述:CRL-11610 RWPE-2 人前列腺正常細胞,原代細胞|細胞系|細胞株|菌種;細胞庫管理規范,提供的細胞株背景清楚,提供參考文獻和*培養條件!

    • 產品型號:CRL-11610
    • 廠商性質:生產廠家
    • 更新時間:2024-03-12
    • 訪  問  量:1818


    Product Category


    Related Articles


    CRL-11610 RWPE-2 人前列腺正常細胞

    ATCC® Number:CRL-11610™    Price:

    Depositors:Michigan State University, National Cancer Institute

    Biosafety Level:2 [Cells contain Human Papilloma viral (HPV) sequences ]


    Medium & Serum:See Propagation

    Growth Properties:adherent

    Organism:Homo sapiens (human)

    Morphology:CRL-11610 RWPE-2 人前列腺正常細胞epithelial

    Source:Organ: prostate
    Disease: normal
    Cell Type: epithelial

    Cellular Products:cytokeratin 18 [46793]

    cytokeratin 8 [46793]

    Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

    Receptors:androgen receptor, expressed ( [46793] upregulated upon exposure to androgen)


    Antigen Expression:kallikrein 3, KLK3 (prostate specific antigen, PSA); Homo sapiens, expressed (upon exposure to androgen) ( [46793] upon exposure to androgen)

    DNA Profile (STR):Amelogenin: X,Y

    CSF1PO: 13

    D13S317: 8,14

    D16S539: 9,11

    D5S818: 12,15

    D7S820: 10,11

    THO1: 8,9.3

    TPOX: 8,11

    vWA: 14,18

    Cytogenetic Analysis:At passage 14, a majority of the cells were in the near diploid range (48-54), with the main population being 51, XY. [46795]

    Isoenzymes:AK-1, 1

    ES-D, 2

    G6PD, B

    GLO-I, 1-2

    Me-2, 0

    PGM1, 2

    PGM3, 1

    Gender:CRL-11610 male

    Ethnicity:Caucasian, White

    Comments:Tumor Suppressor Gene(s):pRB + [PubMed: 9214605]

    RWPE-2 cells were derived from RWPE-1 cells (ATCC CRL-11609) by transformation with Ki-ras using the Kirsten murine sarcoma virus (Ki-MuSV) [PubMed: 9214605]. Epithelial cells from the peripheral zone of a histologically normal adult human prostate were transfected with a plasmid carrying one copy of the human papilloma virus 18 (HPV-18) genome to establish the RWPE-1 cell line (ATCC CRL-11609). RWPE-1 cells neither grow in agar nor form tumors when injected into nude mice with or without Matrigel. However, RWPE-2 cells form small colonies in soft agar and form tumors when injected into nude mice [PubMed: 9214605]. Further, a family of tumorigenic cell lines, that mimics multiple steps in prostate cancer progression, was also derived from RWPE-1 cells by exposure to N-methyl-N-nitrsourea (MNU). See the WPE1-NA22 (ATCCCRL-2849), WPE1-NB14 (ATCC CRL-2850), WPE1-NB11 (ATCC CRL-2851) and WPE1-NB26 (ATCC CRL-2852) cell ines.

    The depositor reports that the RWPE-1 cell line (ATCC CRL-11609) was screened, and found negative for, Hepatitis B virus, Hepatitis C virus and Human immunodeficiency virus.

    Propagation:ATCC complete growth medium: The base medium for this cell line is provided by Invitrogen (GIBCO) as part of a kit: Keratinocyte Serum Free Medium (K-SFM), Kit Catalog Number 17005-042. This kit is supplied with each of the two additives required to grow this cell line (bovine pituitary extract (BPE) and human recombinant epidermal growth factor (EGF). To make the complete growth medium, you will need to add the following components to the base medium:
    • 0.05 mg/ml BPE - provided with the K-SFM kit

    • 5 ng/ml EGF - provided with the K-SFM kit. NOTE: Do not filter complete medium.
      Atmosphere: air, 95%; carbon dioxide (CO2), 5%
      Temperature: 37.0°C

    Subculturing:CRL-11610 Protocol:
    1. Remove and discard culture medium.

    2. Briefly rinse the cell layer with Ca++/Mg++ free Dulbecco's phosphate-buffered saline (D-PBS).

    3. Add 2.0 to 3.0 ml (to a T-25 flask) or 3.0 to 4.0 ml (to a T-75 flask) of 0.05% Trypsin - 0.53mM EDTA solution, diluted 1:1 with D-PBS, and place flask in a 37C incubator for 5 to 8 minutes. Observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 10 minutes).

      Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach.

    4. Add 6.0 to 8.0 ml of 0.1% Soybean Trypsin Inhibitor (or 2% fetal bovine serum in D-PBS), as appropriate, and aspirate cells by gently pipetting.

    5. Transfer cell suspension to centrifuge tube and spin at approximay 125 x g for 5 to 7 minutes.

    6. Discard supernatant and resuspend cells in fresh serum-free growth medium. Add appropriate aliquots of cell suspension to new culture vessels. An inoculum of 2 X 10(4) to 4 X 10(4) viable cells/sq. cm is recommended.

    7. Incubate cultures at 37C. We recommend that you maintain cultures at a cell concentration between 4 X 10(4) and 8 X 10(4) cells/sq. cm.

    Cells grown under serum-free or reduced serum conditions may not attach strongly during the 24 hours after subculture and should be disturbed as little as possible during that period.
    Subc*tion Ratio: A subc*tion ratio of 1:3 to 1:5 is recommended
    Medium Renewal: Every 2 days

    Preservation:Freeze medium: Complete growth medium supplemented with 10% (v/v) DMSO
    Storage temperature: liquid nitrogen vapor phase

    Related Products:parental cell line:ATCC CRL-11609

    purified DNA:ATCC CRL-11610D

    derived from same individual:ATCC CRL-2849

    derived from same individual:ATCC CRL-2850

    derived from same individual:ATCC CRL-2852

    derived from same individual:ATCC CRL-2851

    derivative:ATCC CRL-2853

    derived from same individual:ATCC CRL-2854

    References:46792: Webber MM, Rhim JS. Immortalized and malignant human prostatic cell lines. US Patent 5,824,488 dated Oct 20 1998
    46793: Bello D, et al. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis 18: 1215-1223, 1997. PubMed: 9214605
    46795: Webber MM, et al. Acinar differentiation by non-malignant immortalized human prostatic epithelial cells and its loss by malignant cells. Carcinogenesis 18: 1225-1231, 1997. PubMed: 9214606
    53180: Webber MM, et al. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part I. Cell markers and immortalized nontumorigenic cell lines. Prostate 29: 386-394, 1996. PubMed: 8977636
    53181: Webber MM, et al. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications Part 2. Tumorigenic cell lines. Prostate 30: 58-64, 1997. PubMed: 9018337
    53182: Webber MM, et al. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part 3. Oncogenes, suppressor genes, and applications. Prostate 30: 136-142, 1997. PubMed: 9051152
    53183: Kremer R, et al. ras Activation of human prostate epithelial cells induces overexpression of parathyroid hormone-related peptide. Clin. Cancer Res. 3: 855-859, 1997. PubMed: 9815759
    53192: Jacob K, et al. Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone. Cancer Res. 59: 4453-4457, 1999. PubMed: 10485497



    • 產品:

    • 您的單位:

    • 您的姓名:

    • 聯系電話:

    • 常用郵箱:

    • 省份:

    • 詳細地址:

    • 補充說明:

    • 驗證碼:






    (周一至周日9:00- 19:00)

    • 掃一掃 微信咨詢

    Copyright©2024 上海復祥生物科技有限公司 All Right Reserved    備案號:滬ICP備10013034號-2     sitemap.xml
    技術支持:化工儀器網    管理登陸